Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome

AIMS/INTRODUCTION: Ezetimibe lowers serum lipid levels by inhibiting intestinal absorption of dietary and biliary cholesterol. However, the effect of ezetimibe on insulin resistance remains unclear. The aim of the present study was to examine this issue in patients with metabolic syndrome in local-d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Diabetes Investig
Egile Nagusiak: Ohbu-Murayama, Kyoko, Adachi, Hisashi, Hirai, Yuji, Enomoto, Mika, Fukami, Ako, Obuchi, Aya, Yoshimura, Ayako, Nakamura, Sachiko, Nohara, Yume, Nakao, Erika, Umeki, Yoko, Fukumoto, Yoshihiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420565/
https://ncbi.nlm.nih.gov/pubmed/25969718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12298
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak